A multidisciplinary approach to optimizing care of patients treated with alpelisib
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference80 articles.
1. The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment;Qin;PeerJ,2018
2. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting;Thorpe;Nat Rev Cancer,2015
3. The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers;Paplomata;Ther Adv Med Oncol,2014
4. Phosphatidylinositol 3-kinase, growth disorders, and cancer;Goncalves;N Engl J Med,2018
5. Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer;Miller;Breast Cancer Res,2011
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα;Chemical Science;2024
2. Incidence, risk factors, and management of alpelisib‐associated hyperglycemia in metastatic breast cancer;Cancer;2023-09-25
3. Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing;JCO Oncology Practice;2023-09-08
4. STX-478, a Mutant-Selective, Allosteric PI3Kα Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Kα-Mutant Xenografts;Cancer Discovery;2023-08-25
5. Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigm;Chinese Clinical Oncology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3